This metabolite incorporates a PDE selectivity profile similar to sildenafil and an in vitro potency for PDE5 around fifty% of the father or mother drug. Plasma concentrations of the metabolite are close to 40% of People seen for sildenafil, so that the metabolite accounts for around twenty% of sildenafil's pharmacologic consequences.Most often, Vi